Evidence map›Paper›PMID 31933193›Full record

ArticleJournal of neurovirology2020

Genetic variation in alcohol dehydrogenase is associated with neurocognition in men with HIV and history of alcohol use disorder: preliminary findings.

Rowan Saloner, Emily W Paolillo, Maulika Kohli, Sarah S Murray, David J Moore, Igor Grant, Mariana Cherner

Open access · greenAbstract read
In one paragraph

Article in Journal of neurovirology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rowan SalonerJoint Doctoral Program in Clinical Psychology, San Diego State University/University of California San Diego, San Diego, CA, USA. rsaloner@ucsd.edu.ORCID 0000-0002-1351-6183
Emily W PaolilloJoint Doctoral Program in Clinical Psychology, San Diego State University/University of California San Diego, San Diego, CA, USA.
Maulika KohliJoint Doctoral Program in Clinical Psychology, San Diego State University/University of California San Diego, San Diego, CA, USA.
Sarah S MurrayDepartment of Pathology, University of California San Diego, La Jolla, CA, USA.
David J MooreDepartment of Psychiatry, HIV Neurobehavioral Research Program, University of California San Diego, San Diego, CA, USA.
Igor GrantDepartment of Psychiatry, HIV Neurobehavioral Research Program, University of California San Diego, San Diego, CA, USA.
Mariana ChernerDepartment of Psychiatry, HIV Neurobehavioral Research Program, University of California San Diego, San Diego, CA, USA.
University of California San Diego · USSan Diego State University · US

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jessica Lynette Montoya · 2001 to 2026
$50.4M
Translational Methamphetamine AIDS Research Center (TMARC)P50DA026306 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRANT, IGOR · 2009 to 2018
$33.9M
NEUROMOTORP01DA012065 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JERNIGAN, TERRY L. · 1999 to 2009
$17.8M
Alcohol Research in the Science/Practitioner ModelT32AA013525 · NIAAA · SAN DIEGO STATE UNIVERSITY · PI EDWARD P RILEY, ANDREA SPADONI TOWNSEND · 2002 to 2026
$8.4M
Mentoring Clinical Researchers at the Intersection of NeuroHIV and Substance AbuseK24DA040550 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHERNER, MARIANA · 2015 to 2025
$1.8M
COMT Genotype and Risky Decision Making in HIV and Methamphetamine DependenceR01DA026334 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHERNER, MARIANA · 2009 to 2010
$1.1M
SuperAging in HIV-infected Adults: Biopsychosocial Predictors of Neurocognitive Aging TrajectoriesF31AG064989 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SALONER, ROWAN · 2019 to 2021
$118k
Using Ecological Momentary Assessment to Improve Self-Reported Cognitive Functioning among Adults with Comorbid HIV/AIDS and Heavy Alcohol UseF31AA027198 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PAOLILLO, EMILY · 2018 to 2019
$76k
NIAAA NIH HHS F31 AA027198NIAAA NIH HHS T32 AA013525NIA NIH HHS F31 AG064989NIDA NIH HHS K24 DA040550NIDA NIH HHS P01 DA012065NIDA NIH HHS P50 DA026306NIDA NIH HHS R01 DA026334NIMH NIH HHS P30 MH062512
6 · The paper itself

Abstract

The co-occurrence of HIV and alcohol use disorder (AUD) amplifies risk for neural injury and neurocognitive deficits. However, the substantial neurocognitive heterogeneity across HIV+/AUD+ individuals suggests inter-individual differences in vulnerability to the neurotoxicity of comorbid HIV/AUD. Genetic variation in alcohol dehydrogenase (ADH), which metabolizes ethanol, may contribute to inter-individual neurocognitive variability. We evaluated associations between five ADH single-nucleotide polymorphisms (SNPs) and neurocognition in men stratified by HIV and lifetime AUD status. Neurobehavioral assessments were administered to 153 men. Three-way ANOVAs examined the interaction of HIV, AUD, and ADH SNPs on global and domain-specific demographically corrected T scores. Follow-up ANCOVAs adjusted for age, estimated verbal IQ, depression, and remote non-alcohol substance use disorders. HIV/AUD groups differed globally and for verbal fluency, working memory, executive function, and processing speed T scores specifically, with HIV+/AUD+ exhibiting the poorest performance. ADH4 (rs1126671) was associated with large effects on working memory (d = - 1.16, p = .001) and executive function (d = - 0.77, p = .028) selectively in HIV+/AUD+, which remained significant in ANCOVA models. ADH1A (rs3819197) moderated the deleterious effects of HIV+/AUD+ on processing speed such that HIV+/AUD+ related to slower information processing in A allele carriers but not GG homozygotes (ps < 0.03). Preliminary findings suggest genetic variation in the ADH pathway moderates the deleterious neurocognitive effects of comorbid HIV/AUD. Differential metabolism of heavy ethanol exposure may compromise neurocognition under conditions of neurobiological stress, such as in HIV infection. The functional effects on ethanol metabolism of ADH SNPs examined in this study remain poorly understood, warranting further examination of pharmacokinetic mechanisms mediating ADH gene-neurobehavior relationships in HIV.

Indexed as

AdultAlcohol DehydrogenaseAlcoholismCognitionCognition DisordersCross-Sectional StudiesHIV InfectionsHumansMaleMiddle AgedPolymorphism, Single NucleotideRetrospective StudiesAlcohol DehydrogenaseAlcoholAlcohol dehydrogenaseCognitionHIV-associated neurocognitive disorderSingle-nucleotide polymorphism

Identifiers

PMID31933193
PMCPMC7261244
OpenAlexW3005046132

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.